Project profile — Accelerating Detection of Tuberculosis

• Africa, regional (67.00%)
• Asia, regional (33.00%)

• Basic Health: Tuberculosis control (12263) (100.00%)

• Gender equality (not targeted)
• Children's issues (not targeted)
• Desertification (not targeted)
• Urban issues (not targeted)
• Participatory development and good governance (not targeted)
• Climate change mitigation (not targeted)
• Climate Change Adaptation (not targeted)
• Trade development (not targeted)
• ICT as a tool for development (significant objective)
• Youth Issues (not targeted)
• Biodiversity (not targeted)
• Indigenous Issues (not targeted)
• Environmental sustainability (cross-cutting) (not targeted)
• Disability (not targeted)

This project is a component of the TB REACH initiative, which began operations in early 2010. The project provides a funding mechanism to address urgent needs, gaps, and bottlenecks in tuberculosis (TB) control. It works through the partners of the Stop TB Partnership to support local initiatives in collaboration with national TB control programs. The project provides opportunities for Stop TB partners to implement new and innovative or tried-and-tested solutions in tuberculosis prevention, care, treatment and support among populations that are currently under-serviced. This project focuses specifically on building capacity within TB control programs to address issues including infection control, targeting high-risk groups, training lab technicians and health staff, and rehabilitating laboratories.

N/A

Results achieved as of the end of the project, March 2016, include: (1) 144 projects were funded in 46 countries to test and demonstrate new and innovative approaches to improve tuberculosis (TB) case detection and treatment; (2) active efforts to prioritize and identify cases of tuberculosis among children, mining-affected communities, migrants, indigenous populations, ethnic minorities, prisoners, and hard to reach populations were made; (3) supported a range of innovations, including mobile phone health screening tools and public-private partnerships; (4) contributed to the detection of over 1.9 million people with tuberculosis in project areas and 89% of them were put on treatment; (5) leveraged US$100 million of additional funding to sustain or expand successful initiatives funded by TB REACH; (6) delivered conference presentations and published 37 peer-reviewed scientific journal articles to share results and lessons learned; (7) facilitated the introduction and assessment of a new diagnostic tool (Xpert MTB/RIF) in various settings, contributing to the evidence base for a new World Health Organization (WHO) policy on the use of the test; (8) detected 104,087 additional cases of TB (after adjusting for historical trends) that would otherwise have remained undetected, unreported, and untreated; and (9) saved an estimated 900,000 lives as a result of increased detection and treatment of tuberculosis. These results have contributed to global efforts to help reduce the global burden of tuberculosis.

• Proactive disclosure